ARX:ASX
Aroa Biosurgery Ltd
0,51 AUD
arrow_upward
+0,99%(+0,0050) 1D
10 ნოე, 16:10:23 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 AUD
High
0,52 AUD
Low
0,50 AUD
Mkt. cap
174,68 მლნ.
Avg. vol.
299,41 ათ.
Volume
78,65 ათ.
P/E ratio
49,09
52-wk high
0,78 AUD
52-wk low
0,46 AUD
EPS
0,01 AUD
Shares outstanding
345,90 მლნ.
No. of employees
261
Open
0,50 AUD
High
0,52 AUD
Low
0,50 AUD
Mkt. cap
174,68 მლნ.
Avg. vol.
299,41 ათ.
Volume
78,65 ათ.
P/E ratio
49,09
52-wk high
0,78 AUD
52-wk low
0,46 AUD
EPS
0,01 AUD
Shares outstanding
345,90 მლნ.
No. of employees
261
News stories
From web sources and news partners
markets.businessinsider.com
·
29 წუთის წინ
Dow and ISN® Celebrate More Than 20 Years of Advancing Contractor Safety and Compliance
Seeking Alpha
·
30 წუთის წინ
Inflation goes broad: 76.3% of CPI basket rising faster than 2% pace (SP500:)
Investing.com
·
20 წუთის წინ
Stocks Rebound Sharply, but Is the Worst Over?
Barron's
·
40 წუთის წინ
The SEC Is Pushing for Stock Tokenization. Why Nasdaq Isn’t on Board Yet.
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd